Baseline co-medications may alter the anti-tumoural effect of checkpoint inhibitors as well as the risk of immune-related adverse events
Domains
Bioinformatics [q-bio.QM]Origin | Files produced by the author(s) |
---|
Origin | Files produced by the author(s) |
---|
Accord Elsevier CCSD : Connect in order to contact the contributor
https://hal.science/hal-03671495
Submitted on : Monday, October 16, 2023-1:31:33 PM
Last modification on : Tuesday, April 9, 2024-10:24:12 AM
Long-term archiving on : Wednesday, January 17, 2024-8:23:25 PM